| scholarly article | Q13442814 |
| P50 | author | Teal S. Hallstrand | Q51141702 |
| P2093 | author name string | M H Gelb | |
| Z Ni | |||
| Y Lai | |||
| W R Henderson | |||
| S E Wenzel | |||
| R C Oslund | |||
| P2860 | cites work | Characterization of phospholipase A2 from human nasal lavage | Q72031023 |
| Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society | Q73286389 | ||
| Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids | Q73730745 | ||
| Eosinophilic inflammation in sputum of poorly controlled asthmatics | Q78722730 | ||
| Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities | Q79865384 | ||
| Plasma phospholipase A2 activity in patients with asthma: association with body mass index and cholesterol concentration | Q80487964 | ||
| Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice | Q81317312 | ||
| Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum | Q81702319 | ||
| Dietary salt, airway inflammation, and diffusion capacity in exercise-induced asthma | Q81833336 | ||
| Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis | Q28210542 | ||
| Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells | Q31156335 | ||
| Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha | Q33199057 | ||
| Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program | Q33725032 | ||
| Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. | Q33947290 | ||
| Airway immunopathology of asthma with exercise-induced bronchoconstriction | Q36088242 | ||
| Inflammatory basis of exercise-induced bronchoconstriction | Q36091759 | ||
| Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model | Q36229287 | ||
| Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. | Q36308410 | ||
| Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness | Q36330573 | ||
| Antigen-induced generation of lyso-phospholipids in human airways. | Q36366671 | ||
| Lung mast cells are a source of secreted phospholipases A2 | Q37458766 | ||
| An update on the role of leukotrienes in asthma | Q37633331 | ||
| Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study | Q43616386 | ||
| Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. | Q44164559 | ||
| Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma | Q46413563 | ||
| Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction | Q46418175 | ||
| Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. | Q53619823 | ||
| Induced Sputum Eicosanoid Concentrations in Asthma | Q55094021 | ||
| Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics | Q58857468 | ||
| P433 | issue | 6 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 801-810 | |
| P577 | publication date | 2011-01-24 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Relationship between levels of secreted phospholipase A₂ groups IIA and X in the airways and asthma severity | |
| P478 | volume | 41 |
| Q35776615 | A new era of secreted phospholipase A₂ |
| Q46726763 | Additional insights into epithelial secreted phospholipase A2 group X in asthma |
| Q92243934 | Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis |
| Q24622742 | Blockade of human group X secreted phospholipase A2 (GX-sPLA2)-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective GX-sPLA2 inhibitor |
| Q33783995 | Cellular Na+ handling mechanisms involved in airway smooth muscle contraction (Review) |
| Q59050854 | Diverse Functions of Secretory Phospholipases A2 |
| Q58764843 | Eicosanoid Control Over Antigen Presenting Cells in Asthma |
| Q36414954 | Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils. |
| Q36264207 | Epigenetic modifying enzyme expression in asthmatic airway epithelial cells and fibroblasts |
| Q36768951 | Epithelial regulation of eicosanoid production in asthma |
| Q90357108 | Function of secreted phospholipase A2 group-X in asthma and allergic disease |
| Q37612267 | Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation. |
| Q57293438 | Harmful and protective roles of group V phospholipase A: Current perspectives and future directions |
| Q50990163 | Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A2 (sPLA2). |
| Q40603304 | Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma |
| Q33784887 | Induced sputum proteome in healthy subjects and asthmatic patients |
| Q34602287 | Key role of group v secreted phospholipase A2 in Th2 cytokine and dendritic cell-driven airway hyperresponsiveness and remodeling |
| Q35787395 | New insights into pathogenesis of exercise-induced bronchoconstriction. |
| Q37098084 | PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation |
| Q26997377 | Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention |
| Q38072094 | Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010--present). |
| Q37074836 | Regulation and function of epithelial secreted phospholipase A2 group X in asthma |
| Q37149221 | Role of cells and mediators in exercise-induced bronchoconstriction |
| Q47334197 | Secreted PLA2 group X orchestrates innate and adaptive immune responses to inhaled allergen |
| Q35672868 | Secretory phospholipases A2 are secreted from ciliated cells and increase mucin and eicosanoid secretion from goblet cells |
| Q90393410 | The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy |
| Q38987762 | The Roles of the Secreted Phospholipase A2 Gene Family in Immunology |
| Q37191456 | The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease |
| Q27024735 | The role of prostaglandins in allergic lung inflammation and asthma |
| Q34177286 | The step further to understand the role of cytosolic phospholipase A2 alpha and group X secretory phospholipase A2 in allergic inflammation: pilot study. |
| Q33732168 | Update in asthma 2013 |
Search more.